DSM-Firmenich AG
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by PR-Newswire.
KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, Oct. 31, 2024 /PRNewswire/ --
Management Report
Q3 2024 highlights
Strong improvement of financial resultsSynergies and vitamin transformation programs firmly on trackAnimal Nutrition & Health separation well advancedStrategic portfolio fine-tuning progressing with the sale of marine lipids and yeast extractsHigher vitamin prices reflected in Animal Nutrition & Health contracts as of Q4Full-year outlook increased: Adjusted EBITDA towards €2.1 billion
KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, Oct. 2, 2024 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health and beauty, today announces the completion of the sale of its yeast extract business to Lesaffre, a global player in fermentation and microorganisms. The sale of the yeast extract business was announced on June 12, 2024.
As part of the transaction, 46 dsm-firmenich employees working on yeast extracts will transfer to Lesaffre. Financial details will not be disclosed.
